Literature DB >> 2572742

Mumps meningitis and MMR vaccination.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2572742

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

Review 1.  Rational use of measles, mumps and rubella (MMR) vaccine.

Authors:  H Carter; H Campbell
Journal:  Drugs       Date:  1993-05       Impact factor: 9.546

Review 2.  Life-Threatening Infections Due to Live-Attenuated Vaccines: Early Manifestations of Inborn Errors of Immunity.

Authors:  Laura Pöyhönen; Jacinta Bustamante; Jean-Laurent Casanova; Emmanuelle Jouanguy; Qian Zhang
Journal:  J Clin Immunol       Date:  2019-05-23       Impact factor: 8.317

3.  Seroepidemiology of mumps in the general population of Jiangsu province, China after introduction of a one-dose measles-mumps-rubella vaccine.

Authors:  Yuanbao Liu; Ying Hu; Xiuying Deng; Zhiguo Wang; Peishan Lu; Fubao Ma; Minghao Zhou; Pei Liu; Jie Min
Journal:  Sci Rep       Date:  2015-10-01       Impact factor: 4.379

4.  Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination.

Authors:  Silvia Perez-Vilar; Daniel Weibel; Miriam Sturkenboom; Steven Black; Christine Maure; Jose Luis Castro; Pamela Bravo-Alcántara; Caitlin N Dodd; Silvana A Romio; Maria de Ridder; Swabra Nakato; Helvert Felipe Molina-León; Varalakshmi Elango; Patrick L F Zuber
Journal:  Vaccine       Date:  2017-05-27       Impact factor: 3.641

5.  Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children.

Authors:  V Usonis; V Bakasenas; K Chitour; R Clemens
Journal:  Infection       Date:  1998 Jul-Aug       Impact factor: 7.455

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.